GIST: Clinical Trials

1 trial for GIST, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Terminated 1

Follow GIST: new trials by email Literature Review of GIST trials Research Report on GIST

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Trial of Tasigna (Nilotinib) 400 mg Twice Daily Alone or With Gleevec (Imatinib Mesylate) 400 mg Daily for Patients With Advanced Gastrointestinal Stromal Tumor (GIST)
Nilotinib, Nilotinib with Imatinib - GIST, Metastatic Disease
Phase 2TerminatedFox Chase Cancer Center52009-02-012017-03-15

Narrower conditions

Neoplasm Metastasis (1)

Broader conditions

Neoplasms (1)  ·  Neoplastic Processes (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Interventions

Imatinib Mesylate (1)  ·  nilotinib (1)

Sponsors

Fox Chase Cancer Center (1)

Countries

United States (1)

Top investigators

Margaret von Mehren, MD (1)